(Q38006994)

English

Current polio global eradication and control policy options: perspectives from modeling and prerequisites for oral poliovirus vaccine cessation.

scientific article published on April 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22551030%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Current polio global eradication and control policy options: perspectives from modeling and prerequisites for oral poliovirus vaccine cessation (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22551030%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

eradication of infectious diseases

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

object named as

poliovirus

1 reference

based on heuristic

inferred from title

Kimberly M. Thompson

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22551030%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Radboud J Duintjer Tebbens

2

object named as

Radboud J Duintjer Tebbens

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22551030%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

publication date

1 April 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22551030%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Expert Review of Vaccines

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22551030%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22551030%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22551030%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

449-459

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22551030%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Vaccine policy changes and epidemiology of poliomyelitis in the United States

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.195

21 January 2018

VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION *

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.195

21 January 2018

Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.195

21 January 2018

Costs and benefits of polio eradication: a long-run global perspective

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.195

21 January 2018

Global health goals: lessons from the worldwide effort to eradicate poliomyelitis

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.195

21 January 2018

Retrospective cost-effectiveness analyses for polio vaccination in the United States.

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.195

21 January 2018

Economic analysis of the global polio eradication initiative.

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.195

21 January 2018

Eradication versus control for poliomyelitis: an economic analysis.

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.195

21 January 2018

The polio eradication effort has been a great success--let's finish it and replace it with something even better

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.195

21 January 2018

Risks of paralytic disease due to wild or vaccine-derived poliovirus after eradication.

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.195

21 January 2018

Evaluation of response scenarios to potential polio outbreaks using mathematical models

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.195

21 January 2018

A dynamic model of poliomyelitis outbreaks: learning from the past to help inform the future

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.195

21 January 2018

The costs of future polio risk management policies.

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.195

21 January 2018

Public health. Is polio eradication realistic?

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.195

21 January 2018

Outbreak of type 2 vaccine-derived poliovirus in Nigeria: emergence and widespread circulation in an underimmunized population

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.195

21 January 2018

Transmissibility and persistence of oral polio vaccine viruses: implications for the global poliomyelitis eradication initiative

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.195

21 January 2018

Seroprevalence of antibody against poliovirus in inner-city preschool children. Implications for vaccination policy in the United States

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.195

21 January 2018

Monovalent type 1 oral poliovirus vaccine in newborns

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.195

21 January 2018

Mucosal immunity after vaccination with monovalent and trivalent oral poliovirus vaccine in India

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.195

21 January 2018

The trend of acquired immunity with live poliovirus vaccine and the effect of revaccination: follow-up of vaccinees for ten years.

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.195

21 January 2018

Long-term immunity to poliovirus in children immunized with live attenuated and enhanced-potency inactivated trivalent poliovirus vaccines

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.195

21 January 2018

Intrafamilial and interfamilial spread of living vaccine strains of polioviruses

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.195

21 January 2018

Paralytic poliomyelitis: seasoned strategies, disappearing disease

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.195

21 January 2018

Study designs for evaluating different efficacy and effectiveness aspects of vaccines

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.195

21 January 2018

Protective efficacy of a monovalent oral type 1 poliovirus vaccine: a case-control study

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.195

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38006994&oldid=2163874520"